STAT

And now, your nominees for worst biopharma CEO of 2017. Let the voting begin!

There's always a crop of CEOs who manage to screw up badly enough to make the rest of us cringe. Here are my nominees for the worst of the year.…

Yesterday, I brought you the nice. Today, it’s the naughty: the nominees for the worst biopharma CEO of 2017.

Even in a good year for biopharma, there’s always a crop of CEOs, through their actions or words, who manage to screw up badly enough to make the rest of us cringe.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related Books & Audiobooks